Nonsteroidal Anti-inflammatory Drugs and Risk of Esophageal and Gastric Cancer
Open Access
- 1 February 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 14 (2), 444-450
- https://doi.org/10.1158/1055-9965.epi-04-0467
Abstract
Introduction: Nonsteroidal anti-inflammatory drugs (NSAID) might reduce risks of esophageal and gastric cancer, but previous studies are limited and provide somewhat conflicting results. Methods: We tested these associations in a prospective, nested case-control study based on the General Practitioners Research Database, including over 2 million persons in the United Kingdom between 1994 and 2001. In multivariate analyses we calculated odds ratios (OR) with 95% confidence intervals (95% CI). Data were stratified by history of upper gastrointestinal (UGI) disorders and recalculated using 2 years lag time on data (i.e., excluding all information 2 years before index date). Results: Among 4,340,207 person-years of follow-up, we identified 909 patients with esophageal cancer and 1,023 patients with gastric cancer. We randomly selected 10,000 control subjects. Overall analysis suggested that long-term users of nonaspirin NSAIDs were at reduced risks of esophageal (OR, 0.82; 95% CI, 0.57-1.18) and gastric cancer (OR, 0.65; 95% CI, 0.44-0.94), whereas long-term aspirin users might be at decreased risk of esophageal cancer (OR, 0.76; 95% CI, 0.53-1.08), but not of gastric cancer (OR, 1.09; 95% CI, 0.82-1.45). All estimates of reduced risk were weakened in the 2 years lag time analysis except the association between nonaspirin NSAIDs long-term users and gastric cancer. Potentially protective effects were suggestive of being more marked among subjects with a history of UGI disorders. Conclusions: Nonaspirin NSAIDs long-term use was associated with a reduced risk of gastric cancer, whereas no other studied associations could be firmly established. Our results suggest that UGI disorders could distort the associations, although we could not show this with statistical significance. If such bias was to be true, the previously reported inverse associations might, at least partly, be explained by lack of appropriate adjustment for such disorders.Keywords
This publication has 38 references indexed in Scilit:
- Agreement between GPRD smoking data: a survey of general practitioners and a population‐based surveyPharmacoepidemiology and Drug Safety, 2003
- Confounding by Indication in Epidemiologic Studies of Commonly Used AnalgesicsClinical Journal of Sport Medicine, 2002
- Chemoprevention of gastrointestinal malignancies with nonsteroidal antiinflammatory drugsCancer, 2002
- H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinomaEuropean Journal of Cancer Prevention, 2000
- Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugsThe Lancet, 1994
- Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancerArchives of Internal Medicine, 1994
- Incidence of Cancer Among Patients With Rheumatoid ArthritisJNCI Journal of the National Cancer Institute, 1993
- Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.BMJ, 1991
- 202. Note: Significance Factors for the Ratio of a Poisson Variable to Its ExpectationBiometrics, 1964
- GASTROSCOPIC OBSERVATION OF THE EFFECT OF ASPIRIN AND CERTAIN OTHER SUBSTANCES ON THE STOMACHThe Lancet, 1938